Skip to main content

Breadcrumb

  1. Home
  2. News & Publications
  3. Publications
  4. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.

Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.

Johnson J, Ascierto ML, Mittal S, Newsome D, Kang L, Briggs M, Tanner K, Marincola FM, Berens ME, Vande Woude GF, Xie Q.
Journal of Translational Medicine
PROGRAM:
CTD²
Last Updated: